Class ITerminated

Zenzedi (Dextroamphetamine Sulfate) CII Tablets recall

FDA recall D-0323-2024 · initiated Jan 4, 2024

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Labeling: Label Mix-up

Details

Product: Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03
Recalling company: Azurity
Classification: Class I
Status: Terminated
Type: Voluntary: Firm initiated
Distribution: USA nationwide
Initiated: Jan 4, 2024
FDA report date: Feb 7, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0323-2024 ↗

← All drug recalls